Filing Flows › ICU Medical (ICUI) › How it makes money
How ICU Medical (ICUI) makes money
ICU Medical (ICUI) made $560M of revenue in the third quarter 2026 (Q3 2026), +4% from a year earlier. Infusion Consumables brought in $298M (53%); Infusion Systems brought in $193M (34%); Vital Care brought in $69.5M (12%). Of every dollar of revenue, 42¢ was left as gross profit, 9¢ was left as operating profit, 5¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Infusion Consumables | $298M | 53.2% | +3% | +5% |
| Infusion Systems | $193M | 34.4% | +2% | +11% |
| Vital Care | $69.5M | 12.4% | -5% | -11% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $560M | 100.0% |
| Cost of revenue | $326M | 58.1% |
| Gross profit | $235M | 41.9% |
| Operating expenses | $182M | 32.6% |
| Operating profit | $52.3M | 9.3% |
| Income tax | $7.2M | 1.3% |
| Net earnings | $26.8M | 4.8% |
| Operating cash flow | $99.6M | 17.8% |
| Free cash flow | $83.4M | 14.9% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $560M | +4% |
| Q2 2026 | $552M | +0.5% |
| Q1 2026 | $530M | -12% |
| Q3 2025 | $537M | -9% |
| Q2 2025 | $549M | -8% |
| Q1 2025 | $605M | +7% |
From ICU Medical's 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does ICU Medical make money?
ICU Medical (ICUI) made $560M of revenue in the third quarter 2026 (Q3 2026), +4% from a year earlier. Infusion Consumables brought in $298M (53%); Infusion Systems brought in $193M (34%); Vital Care brought in $69.5M (12%). Of every dollar of revenue, 42¢ was left as gross profit, 9¢ was left as operating profit, 5¢ was left as net earnings.
What is ICU Medical's biggest business?
Infusion Consumables: $298M in the third quarter 2026, 53% of revenue, +5% from a year earlier.
What is ICU Medical's profit margin?
Net earnings were $26.8M, 4.8% of revenue, in the third quarter 2026; the operating margin was 9.3%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.